Millipore Sigma Vibrant Logo
 

disease


6457 Results Advanced Search  
Showing

Narrow Your Results Use the filters below to refine your search

By Application

  • (21)
  • (5)
  • (4)
  • (1)
  • (1)
  • Show More

By Brand

  • (12)
  • (7)
  • (1)
  • (1)
  • (1)
  • Show More

By Industry

  • (59)
  • (15)
  • (10)
  • (9)
  • (3)
Can't Find What You're Looking For?
Contact Customer Service

 
  • Cardiac Antibodies | Merck

    Cardiovascular disease (CVD) is the leading cause of death worldwide. In 2012 an estimated 17.5 million people died of CVDs, representing 31% of total global deaths. Heart failure is the leading cause of hospitalization with more than 1 million cases annually in Europe and North America.
  • 3D Cell Model of Alzheimer's Disease | Life Science Research | Merck

    Using a 3D cell model of Alzheimer's disease can enhance studies of this form of age-related dementia, characterized by progressive memory loss and cognitive impairment. A recently developed protocol for making such a 3D cell model uses ReNcell® VM human neural stem cells, and the relevant protocols are described here.
  • Infectious Diseases | Life Science Research | Merck

    Now that Chemicon® is part of Merck, we offer over twenty years of experience with infectious disease antibodies and kits. Our exclusive Light Diagnostics™ line is recognized as one of the original and leading brands in immunofluorescence diagnostics technology.
  • Controls and Standards | IVD/OEM Materials and Reagents | Merck

    Infectious diseases remain among the most important threats to public health. The role of IVD manufacturers in developing trustworthy assays for diagnosing infections has never been more critical. Reliable calibration and quality control materials are essential in this effort.
  • Next Generation Sequencing | Life Science Research | Merck

    Next Generation Sequencing (NGS) technology can allow unprecedented, gigabase (gb)-length sequencing of genomic DNA per run. In addition to the utility of NGS in gene target resequencing and deciphering genetic biomarkers in disease, NGS-based applications (such as transcriptomics/RNA-sequencing, ChIP-sequencing, single-cell sequencing) provide a high-resolution, multidimensional approach to linking nucleic acid sequences to cell phenotypes.
  • Event | ISCT 2019 | Merck

    Cell therapies are achieving new successes in treating and curing disease in patients around the world. Meet with our team at ISCT.